NewsStackNewsStack
Daily Brief: Which companies are hyping vs delivering: red flags, real signals and repeat offenders, free daily.

KMTS

NASDAQ:KMTSNASDAQ
3 announcements
Credibility Score57%
Kestra Announces Publication of ACE-PAS, the Largest Prospective Real-World Wearable Defibrillator Study, in the Journal of Cardiovascular Electrophysiology
OverhypedModerate hypeunclear

Kestra’s ASSURE WCD delivers 100% shock success in the largest real-world study to date.

about 1 hour ago
▼
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
OverhypedModerate hypeunclear

Kestra secured major debt funding, but operational performance remains a black box for investors.

14 Jul 2026, 20:14 UTC
▼